Point Of Care In Radiology

January 2024 in “ Wiadomości Lekarskie ”

Andrzej Urbanik

TLDR Point of Care in radiology speeds up diagnosis and treatment by performing tests where the patient is.

Point of Care (PoC) is a current trend in medicine that involves performing diagnostic procedures at the location of patient care, such as in a doctor's office or even at the patient's home. This approach accelerates diagnosis and treatment implementation. The author discusses the potential applications of PoC in the field of radiology.

View this study on dx.doi.org →

Discuss this study in the Community →

Semantic ratio: 80%

Related Community Posts Join

6 / 1000+ results

community RU users hands up I wanna hear your miracolous and horror stories.

in Treatment 44 upvotes 3 years ago

The experiences of users who have used RU58841 to treat hair loss, including both positive and negative effects. Some side effects reported include chest pain, joint pain in the hands, tinnitus, and increased heartbeat.

community RU58841 users — how do you find a reliable source?

in Research/Science 2 upvotes 7 months ago

Users discuss finding reliable sources for RU58841, focusing on lab tests, batch consistency, and community reputation. Some mention using alternatives like pyrilutamide.

community Second shed, non-stop flaking, itching

in Treatment 12 upvotes 1 year ago

The user is experiencing a second hair shedding phase and increased flaking and itching while using minoxidil 5% nightly and microneedling every two weeks, with needle length increasing over time. Other users suggest the hair loss may continue without the use of finasteride.

community PP405 is a game changer. One for the history books. Era defining moment and Pelage know it.

in Chat 586 upvotes 6 months ago

PP405 is a new hair loss treatment that may outperform minoxidil and finasteride by growing thick hair in bald areas within four weeks. Its release is expected around 2028, but concerns about its long-term efficacy and cost remain.

community PP405 (Non) Update - Feb 2025

in Research/Science 34 upvotes 1 year ago

The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.

community RU58841 powder from lab supplier tested at free drug testing service.

in Research/Science 8 upvotes 1 year ago

Two Chinese suppliers provided legitimate RU58841, confirmed through a free drug testing service. The vendors were Shaanxi Greenyo Biotech and Lyphar, found on Made-in-China.

Similar Research

5 / 1000+ results